Company Filing History:
Years Active: 2019
Title: Innovations by Gongsheng Li in the Field of Quinolone Derivatives
Introduction: Gongsheng Li, an accomplished inventor based in Shanghai, China, has made significant contributions to the realm of pharmaceutical innovations. His expertise particularly lies in the development of new compounds that enhance bioavailability and efficacy in medical applications.
Latest Patents: Li holds one notable patent titled "Salt of quinolone compound, polymorphs thereof, preparation method therefor, composition, and applications." This patent discloses a salt of a quinoline derivative, alongside its polymorphic forms and preparation methods. The SPH1772 ditartrate or crystal form A exhibited remarkable properties such as high stability, excellent bioavailability, superior pharmacokinetic characteristics, and improved in vivo efficacy compared to the SPH1772 free base.
Career Highlights: Gongsheng Li's career is marked by his affiliation with Shanghai Pharmaceuticals Holding Co., Ltd., where he has contributed to cutting-edge research and development. His innovative work in the pharmaceutical industry has helped pave the way for advancements in drug formulation, particularly in enhancing the therapeutic profiles of quinolone compounds.
Collaborations: Throughout his professional journey, Li has collaborated with notable peers, including Jianxin Yu and Yu Hao. Together, they have focused on various projects aimed at optimizing pharmaceutical compositions and exploring new applications for their inventions.
Conclusion: Gongsheng Li's inventive spirit continues to drive advancements in the pharmaceutical sector. Through his dedicated research and collaboration with esteemed colleagues, he remains a vital contributor to the development of innovative solutions that promise to impact patient care positively.